PULSE › Topics › Avidity
Avidity
3 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✗
Novartis stock experiences a sharp decline following a Phase 3 failure for a dystrophy drug linked to its $12 billion Avidity acquisition.
1 sources
1 articles
v 0
44d ago
◼ Archived
Business
🔮 fades ✓
Novartis shares experienced their worst single-day drop in over two decades following the failure of a crucial phase 3 trial for an Avidity buyout drug.
4 sources
6 articles
v 3
44d ago
◼ Archived
Business
🔮 fades ✗
Novartis shares drop significantly following multiple trial setbacks and difficult dealmaking in the pharmaceutical sector.
10 sources
15 articles
v 12
44d ago
\n
\n
\n